Israel Englander Bridge Bio Pharma, Inc. Call Options Transaction History

Millennium Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $429,395 - $635,065	15,700 New	15,700 $485,000
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $2.66 Million - $3.6 Million	199,900 Added 194.46%	302,700 $5.21 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $737,076 - $1.91 Million	102,800 New	102,800 $1.7 Million

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.21B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.